Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Parkinson disease

Poor results for retinal cell transplants in Parkinson disease

The negative clinical results seen after retinal cell transplantation in patients with Parkinson disease highlight the importance of understanding the mechanisms by which a graft can improve neurological function. Scientific and safety issues must be thoroughly addressed before any cell transplantation approach can progress as a therapy for neurological diseases.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

References

  1. Gross, R. E. et al. Intrastriatal transplantation of microcarrier-bound human retinal pigment epithelial cells versus sham surgery in patients with advanced Parkinson's disease: a double-blind, randomised, controlled trial. Lancet Neurol. 10, 509–519 (2011).

    Article  Google Scholar 

  2. Flores, J. et al. Characterization and survival of long-term implants of human retinal pigment epithelial cells attached to gelatin microcarriers in a model of Parkinson disease. J. Neuropathol. Exp. Neurol. 66, 585–596 (2007).

    Article  CAS  Google Scholar 

  3. Subramanian, T. et al. Striatal xenotransplantation of human retinal pigment epithelial cells attached to microcarriers in hemiparkinsonian rats ameliorates behavioral deficits without provoking a host immune response. Cell Transplant. 11, 207–214 (2002).

    Article  Google Scholar 

  4. Stover, N. P. et al. Intrastriatal implantation of human retinal pigment epithelial cells attached to microcarriers in advanced Parkinson disease. Arch. Neurol. 62, 1833–1837 (2005).

    Article  Google Scholar 

  5. Goetz, C. G. et al. Placebo response in Parkinson's disease: comparisons among 11 trials covering medical and surgical interventions. Mov. Disord. 23, 690–699 (2008).

    Article  Google Scholar 

  6. Cenci, M. A. et al. Animal models of neurological deficits: how relevant is the rat? Nat. Rev. Neurosci. 3, 574–579 (2002).

    Article  CAS  Google Scholar 

  7. Doudet, D. J. et al. PET imaging of implanted human retinal pigment epithelial cells in the MPTP-induced primate model of Parkinson's disease. Exp. Neurol. 189, 361–368 (2004).

    Article  CAS  Google Scholar 

  8. Cepeda, I. L. et al. Human retinal pigment epithelial cell implants ameliorate motor deficits in two rat models of Parkinson disease. J. Neuropathol. Exp. Neurol. 6 6, 576–584 (2007).

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to M. Angela Cenci.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cenci, M., Widner, H. Poor results for retinal cell transplants in Parkinson disease. Nat Rev Neurol 7, 424–425 (2011). https://doi.org/10.1038/nrneurol.2011.111

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrneurol.2011.111

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing